Physician profile
Logan A Oney
NPI 1740397207
$868.94
in general payments reported to CMS, 2019-2025
19 companies · $21.80 in 2025
The $21.80 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $416 · 2021: $107 · 2022: $65.92 · 2023: $47.78 · 2024: $76.62 · 2025: $21.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $203.99 | 2019-2025 | Jardiance, Mounjaro |
| Scilex Pharmaceuticals INC. | $160.94 | 2020-2022 | |
| Novo Nordisk INC | $66.80 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $60.91 | 2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $53.19 | 2019-2020 | |
| Valeritas, INC. | $51.93 | 2019 | |
| Virtus Pharmaceuticals LLC | $43.15 | 2020-2021 | |
| Amarin Pharma, INC. | $30.00 | 2020 | |
| Mannkind Corporation | $28.83 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $21.72 | 2020 | |
| Biodelivery Sciences International, INC. | $20.77 | 2020 | |
| Shire North American Group INC | $20.12 | 2019 | |
| Azurity Pharmaceuticals, INC. | $19.95 | 2023 | Horizant |
| Mdd US Operations, LLC | $18.57 | 2020 | |
| Amphastar Pharmaceuticals, INC. | $15.71 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $15.17 | 2020 | |
| Grt US Holding, INC. | $13.46 | 2021 | |
| Abbott Laboratories | $12.15 | 2020 | |
| Amgen INC. | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Oney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.